<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.pharmacytimes.com/view/why-patients-fear-statins-will-affect-their-memory</loc><lastmod>2026-10-05T20:33:58.811Z</lastmod><news:news><news:publication_date>2026-10-05T20:33:58.811Z</news:publication_date>
        <news:title><![CDATA[Why Patients Fear Statins Will Affect Their Memory ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/pharmacy-technician-day-reflecting-on-the-10-year-evolution-of-the-pharmacy-technician</loc><lastmod>2026-10-05T20:31:57.553Z</lastmod><news:news><news:publication_date>2026-10-05T20:31:57.553Z</news:publication_date>
        <news:title><![CDATA[Pharmacy Technician Day: Reflecting on the 10-Year Evolution of the Pharmacy Technician]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/suzetrigine-after-knee-replacement-are-fewer-opioid-prescriptions-enough-</loc><lastmod>2026-10-05T20:26:53.965Z</lastmod><news:news><news:publication_date>2026-10-05T20:26:53.965Z</news:publication_date>
        <news:title><![CDATA[Suzetrigine After Knee Replacement: Are Fewer Opioid Prescriptions Enough?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/expert-q-a-severe-pneumococcal-infection-may-signal-hidden-blood-cancer-or-immunodeficiency</loc><lastmod>2026-10-05T20:05:36.241Z</lastmod><news:news><news:publication_date>2026-10-05T20:05:36.241Z</news:publication_date>
        <news:title><![CDATA[Expert Q&A: Severe Pneumococcal Infection May Signal Hidden Blood Cancer or Immunodeficiency]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/orforglipron-shows-cv-safety-vs-insulin-glargine-in-achieve-4</loc><lastmod>2026-10-05T18:47:07.030Z</lastmod><news:news><news:publication_date>2026-10-05T18:47:07.030Z</news:publication_date>
        <news:title><![CDATA[Orforglipron Shows CV Safety vs Insulin Glargine in ACHIEVE-4]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/butter-beef-tallow-and-ldl-where-dietary-guidelines-diverge</loc><lastmod>2026-10-05T18:00:00Z</lastmod><news:news><news:publication_date>2026-10-05T18:00:00Z</news:publication_date>
        <news:title><![CDATA[Butter, Beef Tallow, and LDL: Where Dietary Guidelines Diverge]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/ncpa-presents-rep-buddy-carter-with-spirit-of-independence-award</loc><lastmod>2026-10-05T17:33:00.892Z</lastmod><news:news><news:publication_date>2026-10-05T17:33:00.892Z</news:publication_date>
        <news:title><![CDATA[NCPA Presents Rep. Buddy Carter With Spirit of Independence Award]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/why-a-good-income-isn-t-enough</loc><lastmod>2026-10-05T16:59:37.154Z</lastmod><news:news><news:publication_date>2026-10-05T16:59:37.154Z</news:publication_date>
        <news:title><![CDATA[Why a Good Income Isn’t Enough]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/could-linvoseltamab-change-when-we-treat-high-risk-smoldering-myeloma-</loc><lastmod>2026-10-05T16:08:04.842Z</lastmod><news:news><news:publication_date>2026-10-05T16:08:04.842Z</news:publication_date>
        <news:title><![CDATA[Could Linvoseltamab Change When We Treat High-Risk Smoldering Myeloma?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/precision-in-practice-biomarker-testing-and-treatment-selection-in-primary-advanced-or-recurrent-endometrial-cancer</loc><lastmod>2026-10-05T13:00:00Z</lastmod><news:news><news:publication_date>2026-10-05T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Precision in Practice: Biomarker Testing and Treatment Selection in Primary Advanced or Recurrent Endometrial Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/pharmacists-key-to-lp-a-counseling-and-lipid-optimization</loc><lastmod>2026-10-04T19:45:00Z</lastmod><news:news><news:publication_date>2026-10-04T19:45:00Z</news:publication_date>
        <news:title><![CDATA[Pharmacists Key to Lp(a) Counseling and Lipid Optimization ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/ncpa-releases-2026-digest-report</loc><lastmod>2026-10-04T17:46:00Z</lastmod><news:news><news:publication_date>2026-10-04T17:46:00Z</news:publication_date>
        <news:title><![CDATA[NCPA Releases 2026 Digest Report]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/t-j-woodard-named-2026-ncpa-willard-b-simmons-independent-pharmacist-of-the-year</loc><lastmod>2026-10-04T17:45:00Z</lastmod><news:news><news:publication_date>2026-10-04T17:45:00Z</news:publication_date>
        <news:title><![CDATA[T.J. Woodard Named 2026 NCPA Willard B. Simmons Independent Pharmacist of the Year]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/steve-giroux-receives-ncpa-2026-lifetime-achievement-award</loc><lastmod>2026-10-04T17:43:00Z</lastmod><news:news><news:publication_date>2026-10-04T17:43:00Z</news:publication_date>
        <news:title><![CDATA[Steve Giroux Receives NCPA 2026 Lifetime Achievement Award]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/university-of-washington-wins-2026-good-neighbor-pharmacy-ncpa-pruitt-schutte-student-business-plan-competition</loc><lastmod>2026-10-04T17:42:00Z</lastmod><news:news><news:publication_date>2026-10-04T17:42:00Z</news:publication_date>
        <news:title><![CDATA[University of Washington Wins 2026 Good Neighbor Pharmacy NCPA Pruitt-Schutte Student Business Plan Competition]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/jessica-hung-receives-ncpa-foundation-s-nard-ownership-award</loc><lastmod>2026-10-04T17:40:00Z</lastmod><news:news><news:publication_date>2026-10-04T17:40:00Z</news:publication_date>
        <news:title><![CDATA[Jessica Hung Receives NCPA Foundation’s NARD Ownership Award]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/ncpa-foundation-announces-2026-sharlea-leatherwood-memorial-trailblazer-award</loc><lastmod>2026-10-04T17:39:00Z</lastmod><news:news><news:publication_date>2026-10-04T17:39:00Z</news:publication_date>
        <news:title><![CDATA[NCPA Foundation Announces 2026 Sharlea Leatherwood Memorial Trailblazer Award]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/ncpa-foundation-recognizes-megan-smith-as-outstanding-faculty-liaison-of-the-year</loc><lastmod>2026-10-04T17:37:00Z</lastmod><news:news><news:publication_date>2026-10-04T17:37:00Z</news:publication_date>
        <news:title><![CDATA[NCPA Foundation Recognizes Megan Smith as Outstanding Faculty Liaison of the Year]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/blake-torres-receives-national-preceptor-of-the-year-award-from-ncpa-foundation</loc><lastmod>2026-10-04T17:36:00Z</lastmod><news:news><news:publication_date>2026-10-04T17:36:00Z</news:publication_date>
        <news:title><![CDATA[Blake Torres Receives National Preceptor of the Year Award from NCPA Foundation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/ncpa-foundation-announces-2026-scholarship-recipients</loc><lastmod>2026-10-04T17:34:00Z</lastmod><news:news><news:publication_date>2026-10-04T17:34:00Z</news:publication_date>
        <news:title><![CDATA[NCPA Foundation Announces 2026 Scholarship Recipients]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/what-the-2025-2030-dietary-guidelines-mean-for-heart-health</loc><lastmod>2026-10-03T18:00:00Z</lastmod><news:news><news:publication_date>2026-10-03T18:00:00Z</news:publication_date>
        <news:title><![CDATA[What the 2025-2030 Dietary Guidelines Mean for Heart Health ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fda-approves-pirtobrutinib-for-previously-untreated-cll-sll</loc><lastmod>2026-10-02T20:55:11.937Z</lastmod><news:news><news:publication_date>2026-10-02T20:55:11.937Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/increasing-daily-steps-matches-aerobic-training-for-asthma-control-in-randomized-trial</loc><lastmod>2026-10-02T20:45:58.973Z</lastmod><news:news><news:publication_date>2026-10-02T20:45:58.973Z</news:publication_date>
        <news:title><![CDATA[Increasing Daily Steps Matches Aerobic Training for Asthma Control in Randomized Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/why-lp-a-testing-lagged-behind-ldl-cholesterol-screening</loc><lastmod>2026-10-02T19:56:47.499Z</lastmod><news:news><news:publication_date>2026-10-02T19:56:47.499Z</news:publication_date>
        <news:title><![CDATA[Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/who-benefits-most-from-suzetrigine-and-what-stands-in-the-way-</loc><lastmod>2026-10-02T18:46:19.998Z</lastmod><news:news><news:publication_date>2026-10-02T18:46:19.998Z</news:publication_date>
        <news:title><![CDATA[Who Benefits Most From Suzetrigine—and What Stands in the Way?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/how-fes-pet-could-guide-sbrt-selection-in-metastatic-breast-cancer</loc><lastmod>2026-10-02T18:04:00.706Z</lastmod><news:news><news:publication_date>2026-10-02T18:04:00.706Z</news:publication_date>
        <news:title><![CDATA[How FES PET Could Guide SBRT Selection in Metastatic Breast Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/eloratzp-delivers-up-to-23-3-weight-loss-in-adults-with-obesity-and-t2d</loc><lastmod>2026-10-02T18:03:52.611Z</lastmod><news:news><news:publication_date>2026-10-02T18:03:52.611Z</news:publication_date>
        <news:title><![CDATA[EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/american-pharmacists-month-2026-celebrates-250-years-of-pharmacy-care</loc><lastmod>2026-10-02T18:01:58.222Z</lastmod><news:news><news:publication_date>2026-10-02T18:01:58.222Z</news:publication_date>
        <news:title><![CDATA[American Pharmacists Month 2026 Celebrates 250 Years of Pharmacy Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/cagrisema-curbs-food-noise-organ-fat-in-patients-with-obesity-t2d-respectively</loc><lastmod>2026-10-02T17:46:46.261Z</lastmod><news:news><news:publication_date>2026-10-02T17:46:46.261Z</news:publication_date>
        <news:title><![CDATA[CagriSema Curbs 'Food Noise,' Organ Fat in Patients With Obesity, T2D Respectively]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/power-of-platinum-why-these-chemotherapies-still-matter</loc><lastmod>2026-10-02T14:49:47.452Z</lastmod><news:news><news:publication_date>2026-10-02T14:49:47.452Z</news:publication_date>
        <news:title><![CDATA[Power of Platinum: Why These Chemotherapies Still Matter]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/statin-myths-why-patients-avoid-cholesterol-lowering-therapy</loc><lastmod>2026-10-02T14:00:00Z</lastmod><news:news><news:publication_date>2026-10-02T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Statin Myths: Why Patients Avoid Cholesterol-Lowering Therapy ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/pharmacist-advocate-ally-delivering-comprehensive-gender-affirming-care</loc><lastmod>2026-10-01T20:12:26.259Z</lastmod><news:news><news:publication_date>2026-10-01T20:12:26.259Z</news:publication_date>
        <news:title><![CDATA[Pharmacist, Advocate, Ally: Delivering Comprehensive Gender-Affirming Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/semaglutide-2-mg-tied-to-lower-mace-risk-than-tirzepatide-switch</loc><lastmod>2026-10-01T19:47:35.962Z</lastmod><news:news><news:publication_date>2026-10-01T19:47:35.962Z</news:publication_date>
        <news:title><![CDATA[Semaglutide 2 mg Tied to Lower MACE Risk Than Tirzepatide Switch]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/can-suzetrigine-help-patients-stop-opioids-sooner-after-knee-replacement-</loc><lastmod>2026-10-01T18:25:20.347Z</lastmod><news:news><news:publication_date>2026-10-01T18:25:20.347Z</news:publication_date>
        <news:title><![CDATA[Can Suzetrigine Help Patients Stop Opioids Sooner After Knee Replacement?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/invasive-pneumococcal-disease-may-unmask-undiagnosed-blood-cancers-antibody-deficiencies-in-adults</loc><lastmod>2026-10-01T17:00:42.026Z</lastmod><news:news><news:publication_date>2026-10-01T17:00:42.026Z</news:publication_date>
        <news:title><![CDATA[Invasive Pneumococcal Disease May Unmask Undiagnosed Blood Cancers, Antibody Deficiencies in Adults]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/foundational-hfpef-therapy-a-heart-failure-cardiologist-s-view</loc><lastmod>2026-10-01T16:43:40.470Z</lastmod><news:news><news:publication_date>2026-10-01T16:43:40.470Z</news:publication_date>
        <news:title><![CDATA[Foundational HFpEF Therapy: A Heart Failure Cardiologist’s View ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/timing-matters-the-benefit-of-proactive-oncology-pharmacist-intervention</loc><lastmod>2026-10-01T16:42:34.145Z</lastmod><news:news><news:publication_date>2026-10-01T16:42:34.145Z</news:publication_date>
        <news:title><![CDATA[Timing Matters: The Benefit of Proactive Oncology Pharmacist Intervention]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/tirzepatide-linked-to-more-weight-loss-than-semaglutide-7-2-mg</loc><lastmod>2026-10-01T15:45:52.621Z</lastmod><news:news><news:publication_date>2026-10-01T15:45:52.621Z</news:publication_date>
        <news:title><![CDATA[Tirzepatide Linked to More Weight Loss Than Semaglutide 7.2 mg]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fda-expands-mavacamten-label-to-pediatric-patients-with-ohcm</loc><lastmod>2026-10-01T15:16:08.821Z</lastmod><news:news><news:publication_date>2026-10-01T15:16:08.821Z</news:publication_date>
        <news:title><![CDATA[FDA Expands Mavacamten Label to Pediatric Patients With oHCM]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/can-sbrt-keep-breast-cancer-patients-on-treatment-longer-</loc><lastmod>2026-10-01T13:58:59.303Z</lastmod><news:news><news:publication_date>2026-10-01T13:58:59.303Z</news:publication_date>
        <news:title><![CDATA[Can SBRT Keep Breast Cancer Patients on  Treatment Longer?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/september-2026-in-pain-management-4-updates-on-treatment-and-pharmacy-practice</loc><lastmod>2026-09-30T21:55:08.738Z</lastmod><news:news><news:publication_date>2026-09-30T21:55:08.738Z</news:publication_date>
        <news:title><![CDATA[September 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/september-2026-in-hematology-5-updates-that-pharmacists-should-know</loc><lastmod>2026-09-30T20:30:20.525Z</lastmod><news:news><news:publication_date>2026-09-30T20:30:20.525Z</news:publication_date>
        <news:title><![CDATA[September 2026 in Hematology: 5 Updates That Pharmacists Should Know]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/orforglipron-edges-oral-semaglutide-25-mg-in-t2d-indirect-comparison-finds</loc><lastmod>2026-09-30T19:33:58.597Z</lastmod><news:news><news:publication_date>2026-09-30T19:33:58.597Z</news:publication_date>
        <news:title><![CDATA[Orforglipron Edges Oral Semaglutide 25 mg in T2D, Indirect Comparison Finds]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/expert-q-a-vaccine-hesitancy-remains-the-biggest-barrier-to-flu-vaccination</loc><lastmod>2026-09-30T19:13:16.399Z</lastmod><news:news><news:publication_date>2026-09-30T19:13:16.399Z</news:publication_date>
        <news:title><![CDATA[Expert Q&A: Vaccine Hesitancy Remains the Biggest Barrier to Flu Vaccination]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/first-line-hiv-therapy-integrase-inhibitors-exceptions-and-hla-b-5701-testing</loc><lastmod>2026-09-30T18:15:00Z</lastmod><news:news><news:publication_date>2026-09-30T18:15:00Z</news:publication_date>
        <news:title><![CDATA[First-Line HIV Therapy: Integrase Inhibitors, Exceptions, and HLA-B*5701 Testing]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/hiv-treatment-basics-mechanisms-2026-guideline-updates-and-rapid-art-start</loc><lastmod>2026-09-30T18:11:52.389Z</lastmod><news:news><news:publication_date>2026-09-30T18:11:52.389Z</news:publication_date>
        <news:title><![CDATA[HIV Treatment Basics: Mechanisms, 2026 Guideline Updates, and Rapid ART Start]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/september-2026-in-oncology-5-updates-on-treatment-options-and-patient-care</loc><lastmod>2026-09-30T18:00:49.685Z</lastmod><news:news><news:publication_date>2026-09-30T18:00:49.685Z</news:publication_date>
        <news:title><![CDATA[September 2026 in Oncology: 5 Updates on Treatment Options and Patient Care ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/retatrutide-cuts-weight-up-to-18-8-in-adults-with-t2d-obesity</loc><lastmod>2026-09-30T16:13:16.546Z</lastmod><news:news><news:publication_date>2026-09-30T16:13:16.546Z</news:publication_date>
        <news:title><![CDATA[Retatrutide Cuts Weight Up to 18.8% in Adults With T2D, Obesity]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/finerenone-benefits-hold-in-patients-with-a-history-of-cancer</loc><lastmod>2026-09-30T15:00:10.196Z</lastmod><news:news><news:publication_date>2026-09-30T15:00:10.196Z</news:publication_date>
        <news:title><![CDATA[Finerenone Benefits Hold in Patients With a History of Cancer]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/intensive-chemotherapy-in-combination-with-quizartinib-versus-midostaurin-for-flt3-itd-mutated-acute-myeloid-leukemia-a-multicenter-cohort-study</loc><lastmod>2026-09-30T14:30:00Z</lastmod><news:news><news:publication_date>2026-09-30T14:30:00Z</news:publication_date>
        <news:title><![CDATA[Intensive Chemotherapy in Combination With Quizartinib Versus Midostaurin for FLT3-ITD Mutated Acute Myeloid Leukemia: A Multicenter Cohort Study]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/pharmacists-can-close-ckd-medication-adherence-gaps-phti-says</loc><lastmod>2026-09-29T20:01:00Z</lastmod><news:news><news:publication_date>2026-09-29T20:01:00Z</news:publication_date>
        <news:title><![CDATA[Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/pharmacists-as-the-go-to-source-for-hiv-prevention-guidance</loc><lastmod>2026-09-29T20:00:00Z</lastmod><news:news><news:publication_date>2026-09-29T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Pharmacists as the Go-To Source for HIV Prevention Guidance]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/hiv-care-access-why-pharmacy-convenience-and-rapport-matter</loc><lastmod>2026-09-29T19:00:00Z</lastmod><news:news><news:publication_date>2026-09-29T19:00:00Z</news:publication_date>
        <news:title><![CDATA[HIV Care Access: Why Pharmacy Convenience and Rapport Matter ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/sotatercept-in-ers-pah-guidelines-what-pharmacists-should-watch</loc><lastmod>2026-09-29T17:00:00Z</lastmod><news:news><news:publication_date>2026-09-29T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Sotatercept in ERS PAH Guidelines: What Pharmacists Should Watch]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/expert-q-a-researcher-urges-autonomic-assessment-for-patients-with-long-covid</loc><lastmod>2026-09-29T16:53:37.116Z</lastmod><news:news><news:publication_date>2026-09-29T16:53:37.116Z</news:publication_date>
        <news:title><![CDATA[Expert Q&A: Researcher Urges Autonomic Assessment for Patients With Long COVID]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/oncology-pulsepoint-how-asco-s-new-breast-cancer-surveillance-guideline-changes-follow-up</loc><lastmod>2026-09-29T15:32:16.640Z</lastmod><news:news><news:publication_date>2026-09-29T15:32:16.640Z</news:publication_date>
        <news:title><![CDATA[Oncology Pulsepoint: How ASCO’s New Breast Cancer Surveillance Guideline Changes Follow-Up]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fda-approves-tiratricol-first-treatment-for-mct8-deficiency</loc><lastmod>2026-10-02T13:25:54.174Z</lastmod><news:news><news:publication_date>2026-09-29T15:13:11.539Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Tiratricol, First Treatment for MCT8 Deficiency]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/navigating-a-shifting-landscape-at-the-pharmacy-counter-deck-podcast</loc><lastmod>2026-09-29T12:05:00Z</lastmod><news:news><news:publication_date>2026-09-29T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Navigating a Shifting Landscape at the Pharmacy Counter Deck Podcast]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/covid-19-in-2026-navigating-a-shifting-landscape-at-the-pharmacy-counter-deck</loc><lastmod>2026-09-29T12:00:00Z</lastmod><news:news><news:publication_date>2026-09-29T12:00:00Z</news:publication_date>
        <news:title><![CDATA[COVID-19 in 2026: Navigating a Shifting Landscape at the Pharmacy Counter Deck]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/ckd-prevalence-unmoved-despite-billions-in-virtual-care</loc><lastmod>2026-09-28T20:01:00Z</lastmod><news:news><news:publication_date>2026-09-28T20:01:00Z</news:publication_date>
        <news:title><![CDATA[CKD Prevalence Unmoved Despite Billions in Virtual Care ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/what-ai-means-for-eprescribing-faster-better-solutions-for-specialty-and-consumer-practices</loc><lastmod>2026-09-28T18:50:00Z</lastmod><news:news><news:publication_date>2026-09-28T18:50:00Z</news:publication_date>
        <news:title><![CDATA[What AI Means for ePrescribing: Faster, Better Solutions for Specialty and Consumer Practices]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/engineered-stem-cell-therapy-reverses-new-onset-t1d-in-mice-by-reprogramming-t-cells</loc><lastmod>2026-09-28T18:00:00Z</lastmod><news:news><news:publication_date>2026-09-28T18:00:00Z</news:publication_date>
        <news:title><![CDATA[Engineered Stem Cell Therapy Reverses New-Onset T1D in Mice by Reprogramming T Cells]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/crs-with-linvoseltamab-peaks-6-to-8-hours-after-first-step-up-dose</loc><lastmod>2026-09-28T17:00:29.614Z</lastmod><news:news><news:publication_date>2026-09-28T17:00:29.614Z</news:publication_date>
        <news:title><![CDATA[CRS With Linvoseltamab Peaks 6 to 8 Hours After First Step-Up Dose]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fda-approves-tavapadon-first-d1-d5-agonist-for-parkinson-disease</loc><lastmod>2026-09-28T16:59:00.559Z</lastmod><news:news><news:publication_date>2026-09-28T16:59:00.559Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Tavapadon, First D1/D5 Agonist for Parkinson Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/could-suzetrigine-help-patients-avoid-opioid-refills-after-knee-replacement-</loc><lastmod>2026-09-28T16:43:54.482Z</lastmod><news:news><news:publication_date>2026-09-28T16:43:54.482Z</news:publication_date>
        <news:title><![CDATA[Could Suzetrigine Help Patients Avoid Opioid Refills After Knee Replacement?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fda-approves-zilurgisertib-an-oral-alk2-inhibitor-for-fop</loc><lastmod>2026-09-29T15:00:52.514Z</lastmod><news:news><news:publication_date>2026-09-28T16:27:43.873Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Zilurgisertib, an Oral ALK2 Inhibitor, for FOP]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/cagrisema-tops-tirzepatide-5-mg-for-weight-loss-in-reimagine-5</loc><lastmod>2026-09-28T16:04:00Z</lastmod><news:news><news:publication_date>2026-09-28T16:04:00Z</news:publication_date>
        <news:title><![CDATA[CagriSema Tops Tirzepatide 5 mg for Weight Loss in REIMAGINE 5]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/why-5-injectable-drugs-have-been-in-shortage-for-more-than-a-decade</loc><lastmod>2026-09-28T15:22:00Z</lastmod><news:news><news:publication_date>2026-09-28T15:22:00Z</news:publication_date>
        <news:title><![CDATA[Why 5 Injectable Drugs Have Been in Shortage for More Than a Decade]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/ramantamig-s-93-6-orr-and-outpatient-crs-control</loc><lastmod>2026-09-27T13:45:00Z</lastmod><news:news><news:publication_date>2026-09-27T13:45:00Z</news:publication_date>
        <news:title><![CDATA[Ramantamig's 93.6% ORR and Outpatient CRS Control]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/teclistamab-daratumumab-intensification-achieves-73-mrd-negative-cr-rate-in-high-risk-multiple-myeloma</loc><lastmod>2026-09-26T18:08:00Z</lastmod><news:news><news:publication_date>2026-09-26T18:08:00Z</news:publication_date>
        <news:title><![CDATA[Teclistamab-Daratumumab Intensification Achieves 73% MRD-Negative CR Rate in High-Risk Multiple Myeloma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/mrd-guided-maintenance-and-the-question-of-when-to-stop</loc><lastmod>2026-09-26T16:30:00Z</lastmod><news:news><news:publication_date>2026-09-26T16:30:00Z</news:publication_date>
        <news:title><![CDATA[MRD-Guided Maintenance and the Question of When to Stop]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/tec-dara-cuts-death-risk-78-without-raising-fatal-toxicity</loc><lastmod>2026-09-26T13:00:00Z</lastmod><news:news><news:publication_date>2026-09-26T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Tec-Dara Cuts Death Risk 78% Without Raising Fatal Toxicity]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/nearly-two-thirds-of-patients-with-long-covid-meet-diagnostic-criteria-for-pots</loc><lastmod>2026-09-25T20:30:17.365Z</lastmod><news:news><news:publication_date>2026-09-25T20:30:17.365Z</news:publication_date>
        <news:title><![CDATA[Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/mrd-guided-transplant-deferral-remains-feasible-at-nearly-4-years-in-milestone-study</loc><lastmod>2026-09-25T18:57:15.203Z</lastmod><news:news><news:publication_date>2026-09-25T18:57:15.203Z</news:publication_date>
        <news:title><![CDATA[MRD-Guided Transplant Deferral Remains Feasible at Nearly 4 Years in MILESTONE Study]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/etentamig-clears-the-bar-against-standard-therapy-in-triple-class-exposed-myeloma</loc><lastmod>2026-09-25T18:40:33.793Z</lastmod><news:news><news:publication_date>2026-09-25T18:40:33.793Z</news:publication_date>
        <news:title><![CDATA[Etentamig Clears the Bar Against Standard Therapy in Triple-Class Exposed Myeloma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/krd-improves-mrd-negativity-and-pfs-but-raises-toxicity-concerns-in-high-risk-smoldering-myeloma</loc><lastmod>2026-09-25T18:13:00.759Z</lastmod><news:news><news:publication_date>2026-09-25T18:13:00.759Z</news:publication_date>
        <news:title><![CDATA[KRd Improves MRD Negativity and PFS but Raises Toxicity Concerns in High-Risk Smoldering Myeloma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/influenza-vaccines-continue-to-reduce-severe-disease-and-death-across-high-risk-groups-evidence-review-finds</loc><lastmod>2026-09-25T16:48:38.036Z</lastmod><news:news><news:publication_date>2026-09-25T17:47:28.777Z</news:publication_date>
        <news:title><![CDATA[Influenza Vaccines Continue to Reduce Severe Disease and Death Across High-Risk Groups, Evidence Review Finds]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/patients-prefer-at-home-isatuximab-injector-over-iv-iraklia-data-show</loc><lastmod>2026-09-25T17:39:39.535Z</lastmod><news:news><news:publication_date>2026-09-25T17:39:39.535Z</news:publication_date>
        <news:title><![CDATA[Patients Prefer At-Home Isatuximab Injector Over IV, IRAKLIA Data Show]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/how-community-pharmacies-help-patients-quit-smoking</loc><lastmod>2026-09-25T16:30:00Z</lastmod><news:news><news:publication_date>2026-09-25T16:30:00Z</news:publication_date>
        <news:title><![CDATA[How Community Pharmacies Help Patients Quit Smoking]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/building-a-bcma-bispecific-around-the-patient-experience-not-just-the-molecule</loc><lastmod>2026-09-25T15:20:00Z</lastmod><news:news><news:publication_date>2026-09-25T15:20:00Z</news:publication_date>
        <news:title><![CDATA[Building a BCMA Bispecific Around the Patient Experience, Not Just the Molecule]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/harnessing-the-gut-microbiome-for-enhanced-car-t-cell-therapy</loc><lastmod>2026-09-25T02:00:00Z</lastmod><news:news><news:publication_date>2026-09-25T02:00:00Z</news:publication_date>
        <news:title><![CDATA[Harnessing the Gut Microbiome for Enhanced CAR T-Cell Therapy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fda-approves-belzutifan-plus-lenvatinib-for-advanced-renal-cell-carcinoma-after-immunotherapy</loc><lastmod>2026-09-24T20:00:07.091Z</lastmod><news:news><news:publication_date>2026-09-24T20:00:07.091Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Belzutifan Plus Lenvatinib for Advanced Renal Cell Carcinoma After Immunotherapy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/cold-spells-heat-waves-raise-heart-failure-risk</loc><lastmod>2026-09-24T19:00:00Z</lastmod><news:news><news:publication_date>2026-09-24T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Cold Spells, Heat Waves Raise Heart Failure Risk]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fda-approves-lirafugratinib-for-previously-treated-fgfr2-altered-cholangiocarcinoma</loc><lastmod>2026-09-24T18:15:58.347Z</lastmod><news:news><news:publication_date>2026-09-24T18:15:58.347Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Lirafugratinib for Previously Treated FGFR2-Altered Cholangiocarcinoma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/iberdomide-pairs-with-isatuximab-to-rescue-mrd-positive-patients-after-transplant</loc><lastmod>2026-09-24T18:00:11.239Z</lastmod><news:news><news:publication_date>2026-09-24T18:00:11.239Z</news:publication_date>
        <news:title><![CDATA[Iberdomide Pairs With Isatuximab to Rescue MRD-Positive Patients After Transplant]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/fda-approves-insulin-efsitora-once-weekly-basal-insulin-injection-for-adults-with-t2d</loc><lastmod>2026-09-24T20:23:23.113Z</lastmod><news:news><news:publication_date>2026-09-24T17:32:09.842Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Insulin Efsitora, Once-Weekly Basal Insulin Injection for Adults With T2D]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/how-sotatercept-is-raising-the-bar-for-pah-treatment-goals</loc><lastmod>2026-09-24T17:00:00Z</lastmod><news:news><news:publication_date>2026-09-24T17:00:00Z</news:publication_date>
        <news:title><![CDATA[How Sotatercept Is Raising the Bar for PAH Treatment Goals ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/daratumumab-maintenance-more-than-doubles-median-pfs-in-long-term-cassiopeia-analysis</loc><lastmod>2026-09-24T16:00:00Z</lastmod><news:news><news:publication_date>2026-09-24T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Daratumumab Maintenance More Than Doubles Median PFS in Long-Term CASSIOPEIA Analysis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/severe-asthma-s-effects-may-extend-beyond-the-lungs-brain-imaging-study-suggests</loc><lastmod>2026-09-23T19:52:50.538Z</lastmod><news:news><news:publication_date>2026-09-23T19:52:50.538Z</news:publication_date>
        <news:title><![CDATA[Severe Asthma's Effects May Extend Beyond the Lungs, Brain Imaging Study Suggests]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/pharmacists-help-reduce-infection-risk-during-bispecific-antibody-treatment-for-multiple-myeloma</loc><lastmod>2026-09-23T18:11:56.286Z</lastmod><news:news><news:publication_date>2026-09-23T18:11:56.286Z</news:publication_date>
        <news:title><![CDATA[Pharmacists Help Reduce Infection Risk During Bispecific Antibody Treatment for Multiple Myeloma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/alcohol-and-glp-1-therapy-key-counseling-points-for-pharmacists</loc><lastmod>2026-09-23T17:00:00Z</lastmod><news:news><news:publication_date>2026-09-23T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Alcohol and GLP-1 Therapy: Key Counseling Points for Pharmacists ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/after-180-years-multiple-myeloma-gets-a-definition-of-cure</loc><lastmod>2026-09-23T16:33:00Z</lastmod><news:news><news:publication_date>2026-09-23T16:33:00Z</news:publication_date>
        <news:title><![CDATA[After 180 Years, Multiple Myeloma Gets a Definition of Cure]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/linvoseltamab-shows-100-response-rate-in-smoldering-myeloma-raising-early-intervention-question</loc><lastmod>2026-09-23T16:00:07.937Z</lastmod><news:news><news:publication_date>2026-09-23T16:00:07.937Z</news:publication_date>
        <news:title><![CDATA[Linvoseltamab Shows 100% Response Rate in Smoldering Myeloma, Raising Early-Intervention Question]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/psilocybin-assisted-therapy-for-aud-emerging-evidence-clinical-and-cost-implications-and-treatment-gaps</loc><lastmod>2026-09-23T15:52:43.347Z</lastmod><news:news><news:publication_date>2026-09-23T15:52:43.347Z</news:publication_date>
        <news:title><![CDATA[Psilocybin-Assisted Therapy for AUD: Emerging Evidence, Clinical and Cost Implications, and Treatment Gaps]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/mezigdomide-plus-elranatamab-produces-significant-response-in-early-melt-mm-analysis</loc><lastmod>2026-09-23T15:18:29.448Z</lastmod><news:news><news:publication_date>2026-09-23T15:18:29.448Z</news:publication_date>
        <news:title><![CDATA[Mezigdomide Plus Elranatamab Produces Significant Response in Early MELT-MM Analysis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/glp-1s-sglt-2s-slow-kidney-decline-but-only-in-those-with-albuminuria</loc><lastmod>2026-09-23T14:43:00Z</lastmod><news:news><news:publication_date>2026-09-23T14:43:00Z</news:publication_date>
        <news:title><![CDATA[GLP-1s, SGLT-2s Slow Kidney Decline, But Only in Those With Albuminuria]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/expert-q-a-pharmacists-address-pneumococcal-vaccine-hesitancy-and-screening-complexity-in-transitions-of-care</loc><lastmod>2026-09-22T20:32:56.676Z</lastmod><news:news><news:publication_date>2026-09-22T20:32:56.676Z</news:publication_date>
        <news:title><![CDATA[Expert Q&A: Pharmacists Address Pneumococcal Vaccine Hesitancy and Screening Complexity in Transitions of Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/armored-car-t-cell-therapy-produces-durable-complete-response-in-pediatric-solid-tumors</loc><lastmod>2026-09-22T20:00:39.200Z</lastmod><news:news><news:publication_date>2026-09-22T20:00:39.200Z</news:publication_date>
        <news:title><![CDATA[Armored CAR T-Cell Therapy Produces Durable Complete Response in Pediatric Solid Tumors]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/enicepatide-meets-primary-end-points-in-phase-2-trial-of-adults-with-type-2-diabetes-obesity</loc><lastmod>2026-09-22T19:30:38.205Z</lastmod><news:news><news:publication_date>2026-09-22T19:30:38.205Z</news:publication_date>
        <news:title><![CDATA[Enicepatide Meets Primary End Points in Phase 2 Trial of Adults With Type 2 Diabetes, Obesity]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.pharmacytimes.com/view/stabilizers-silencers-and-depleters-exploring-new-frontiers-treating-attr-cm</loc><lastmod>2026-09-22T15:24:35.747Z</lastmod><news:news><news:publication_date>2026-09-22T15:24:35.747Z</news:publication_date>
        <news:title><![CDATA[Stabilizers, Silencers, and Depleters: Exploring New Frontiers Treating ATTR-CM]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url></urlset>